Oncology Medical News about bladder cancer

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Macrophage migration inhibitory factor anti-thrombin III complexes are decreased in bladder cancer patient serum: Complex formation as a mechanism of inactivation
Cancer Letters, 09/21/09

Meyer–Siegler KL et al. – Mounting evidence suggests that the pro–inflammatory cytokine macrophage migration inhibitory factor (MIF) may serve as an important link between chronic inflammation and carcinogenesis as evidenced by the increase in serum MIF found in patients with various cancers. Increased circulating levels of bioactive MIF are present in bladder cancer patient serum.

<< Previous
Association Between MGMT Promoter Hypermethylation and p53...

Next >>
FOS Proliferating Network Construction in Early Colorectal Cancer...

High frequency of tumor cells with nuclear Egr-1 protein expression in human bladder cancer is associated with disease progression
BMC Cancer, 11/13/09 Relevance Score: 70%

Evidence-based Principles of Bladder Cancer and Diet
Urology, 10/21/09 Relevance Score: 70%

Incidence analyses of bladder cancer in the Nile delta region of Egypt
Cancer Epidemiology, 10/20/09 Relevance Score: 70%

Biomarkers in bladder cancer
BJU International, 10/01/09 Relevance Score: 70%

Diagnosis and Treatment of Bladder Cancer
American Family Physician, 10/01/09 Relevance Score: 70%